vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $13.2M, roughly 1.7× TriSalus Life Sciences, Inc.). BGSF, INC. runs the higher net margin — -5.3% vs -73.9%, a 68.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -9.4%). BGSF, INC. produced more free cash flow last quarter ($1.7M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -5.3%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
BGSF vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $13.2M |
| Net Profit | $-1.2M | $-9.8M |
| Gross Margin | 35.0% | 86.7% |
| Operating Margin | -17.6% | -24.8% |
| Net Margin | -5.3% | -73.9% |
| Revenue YoY | -9.4% | 59.8% |
| Net Profit YoY | -18.2% | 3.5% |
| EPS (diluted) | $-0.12 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $13.2M | ||
| Q3 25 | $26.9M | $11.6M | ||
| Q2 25 | $23.5M | $11.2M | ||
| Q1 25 | $20.9M | $9.2M | ||
| Q4 24 | $24.3M | $8.3M | ||
| Q3 24 | $29.8M | $7.3M | ||
| Q2 24 | $25.7M | $7.4M | ||
| Q1 24 | $24.5M | $6.5M |
| Q4 25 | $-1.2M | $-9.8M | ||
| Q3 25 | $-5.8M | $-10.8M | ||
| Q2 25 | $-3.7M | $-8.3M | ||
| Q1 25 | $-722.0K | $-10.4M | ||
| Q4 24 | $-981.0K | $-10.1M | ||
| Q3 24 | $-804.0K | $-2.4M | ||
| Q2 24 | $-761.0K | $-4.3M | ||
| Q1 24 | $-792.0K | $-13.2M |
| Q4 25 | 35.0% | 86.7% | ||
| Q3 25 | 35.9% | 83.5% | ||
| Q2 25 | 35.8% | 83.9% | ||
| Q1 25 | 36.2% | 83.7% | ||
| Q4 24 | 35.9% | 85.3% | ||
| Q3 24 | 35.9% | 86.3% | ||
| Q2 24 | 37.3% | 87.6% | ||
| Q1 24 | 38.1% | 85.0% |
| Q4 25 | -17.6% | -24.8% | ||
| Q3 25 | -3.5% | -77.9% | ||
| Q2 25 | -18.8% | -65.4% | ||
| Q1 25 | 1.6% | -79.9% | ||
| Q4 24 | -15.7% | -91.8% | ||
| Q3 24 | -3.4% | -118.9% | ||
| Q2 24 | -5.7% | -111.0% | ||
| Q1 24 | 1.7% | -180.8% |
| Q4 25 | -5.3% | -73.9% | ||
| Q3 25 | -21.6% | -93.5% | ||
| Q2 25 | -15.9% | -73.9% | ||
| Q1 25 | -3.5% | -113.2% | ||
| Q4 24 | -4.0% | -122.4% | ||
| Q3 24 | -2.7% | -32.6% | ||
| Q2 24 | -3.0% | -58.8% | ||
| Q1 24 | -3.2% | -204.5% |
| Q4 25 | $-0.12 | $-0.22 | ||
| Q3 25 | $-0.52 | $-0.96 | ||
| Q2 25 | $-0.34 | $-0.27 | ||
| Q1 25 | $-0.06 | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | $-0.07 | $-0.12 | ||
| Q2 24 | $-0.07 | $-0.21 | ||
| Q1 24 | — | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $-33.9M |
| Total Assets | $57.8M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | $41.2M | $22.7M | ||
| Q2 25 | $2.8M | $26.5M | ||
| Q1 25 | $2.0M | $13.0M | ||
| Q4 24 | $32.0K | $8.5M | ||
| Q3 24 | $262 | $11.3M | ||
| Q2 24 | $226 | $16.5M | ||
| Q1 24 | $50 | $4.0M |
| Q4 25 | $48.1M | $-33.9M | ||
| Q3 25 | $50.7M | $-26.7M | ||
| Q2 25 | $78.3M | $-19.4M | ||
| Q1 25 | $81.8M | $-34.4M | ||
| Q4 24 | $82.3M | $-25.9M | ||
| Q3 24 | $82.9M | $-20.4M | ||
| Q2 24 | $83.2M | $-25.3M | ||
| Q1 24 | $83.6M | $-36.0M |
| Q4 25 | $57.8M | $35.3M | ||
| Q3 25 | $83.6M | $36.5M | ||
| Q2 25 | $149.7M | $41.3M | ||
| Q1 25 | $152.3M | $28.6M | ||
| Q4 24 | $150.1M | $24.0M | ||
| Q3 24 | $157.3K | $27.5M | ||
| Q2 24 | $159.8K | $32.4M | ||
| Q1 24 | $170.6K | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $-2.5M |
| Free Cash FlowOCF − Capex | $1.7M | $-2.5M |
| FCF MarginFCF / Revenue | 7.6% | -19.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $-2.5M | ||
| Q3 25 | $-4.8M | $-3.7M | ||
| Q2 25 | $2.2M | $-7.3M | ||
| Q1 25 | $1.1M | $-4.5M | ||
| Q4 24 | $3.2M | $-5.7M | ||
| Q3 24 | $6.5M | $-10.8M | ||
| Q2 24 | $7.3M | $-13.4M | ||
| Q1 24 | $7.4M | $-10.9M |
| Q4 25 | $1.7M | $-2.5M | ||
| Q3 25 | $-4.9M | $-3.9M | ||
| Q2 25 | $2.1M | $-7.4M | ||
| Q1 25 | $1.0M | $-5.3M | ||
| Q4 24 | $2.5M | $-5.8M | ||
| Q3 24 | $6.5M | $-11.0M | ||
| Q2 24 | $7.3M | $-13.5M | ||
| Q1 24 | $6.9M | $-10.9M |
| Q4 25 | 7.6% | -19.1% | ||
| Q3 25 | -18.1% | -33.9% | ||
| Q2 25 | 9.1% | -66.1% | ||
| Q1 25 | 5.0% | -57.3% | ||
| Q4 24 | 10.2% | -69.7% | ||
| Q3 24 | 21.7% | -149.9% | ||
| Q2 24 | 28.5% | -183.1% | ||
| Q1 24 | 28.1% | -169.3% |
| Q4 25 | 0.1% | 0.3% | ||
| Q3 25 | 0.4% | 1.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 8.2% | ||
| Q4 24 | 3.0% | 0.6% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 2.0% | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
TLSI
Segment breakdown not available.
